Omeros Corporation Stock Analysis & AI Score
Omeros Corporation (OMER) has an ST Score of 62.6 (B), driven by its Growth (A) and held back by its Financial Strength (C). Analysts rate it Buy with a $27.50 price target (+36.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Omeros Corporation (OMER) has an ST Score of 62.6 (B), driven by its Growth (A) and held back by its Financial Strength (C). Analysts rate it Buy with a $27.50 price target (+36.6% upside).
- Strongest
- GrowthA
- Weakest
- Financial StrengthC
All factor grades
- GrowthA
- MomentumA-
- ForecastA-
- ProfitabilityC+
- ValuationC
- Financial StrengthC
- Piotroski6/9
Contact
OMER stock: frequently asked questions
What is OMER's ST Score?
Omeros Corporation (OMER) has an ST Score of 62.6 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is OMER a buy, hold, or sell?
Analysts rate OMER a Buy, with a price target of $27.50 (+36.6% vs the current price). Our ST Score grades it B (62.6/100). The ST Score is a data-driven signal, not a recommendation.
What are OMER's factor grades?
Valuation C, Profitability C+, Financial Strength C, Momentum A-, Growth A, Forecast A-.
What is OMER's valuation grade?
Omeros Corporation (OMER) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is OMER's growth grade?
Omeros Corporation (OMER) earns a growth grade of A, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is OMER's profitability grade?
Omeros Corporation (OMER) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is OMER's financial strength grade?
Omeros Corporation (OMER) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for OMER?
The average analyst price target for Omeros Corporation (OMER) is $27.50 from 19 analysts, which is +36.6% versus the recent price of $20.13.
What is OMER's Piotroski score?
Omeros Corporation (OMER) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.